⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11357423 | 0.89 | CYP11B2 (0.36) | — | |
| SCHEMBL17260763 | 0.89 | TRIM24 (0.43) | — | |
| SCHEMBL17260812 | 0.87 | TRIM24 (0.46) | — | |
| SCHEMBL17260750 | 0.87 | TRIM24 (0.46) | — | |
| SCHEMBL19951605 | 0.84 | — | — | |
| SCHEMBL329065 | 0.84 | TRIM24 (0.43) | — | |
| SCHEMBL14842917 | 0.74 | — | — | |
| SCHEMBL28881361 | 0.74 | — | — | |
| SCHEMBL12183121 | 0.72 | — | — | |
| SCHEMBL6618 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113789527-B | Electrochemical synthesis method of aromatic amine | 四川大学 | 2023-02-28 | — | — | CN | claimed |
| CN-113789527-A | Electrochemical synthesis method of aromatic amine | 四川大学 | 2021-12-14 | — | — | CN | claimed |
| US-20260098032-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | PMV PHARMACEUTICALS INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-12595253-B2 | Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2026-04-07 | — | — | US | disclosed |
| US-12583858-B2 | TDO2 inhibitors | GENENTECH, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| EP-4663640-A1 | XANTHINE COMPOUND AND USE THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2025-12-17 | — | — | EP | disclosed |
| EP-4644387-A2 | METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION | PMV Pharmaceuticals, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| US-20250320224-A1 | NOVEL PAR-2 INHIBITORS | DOMAIN THERAPEUTICS (FR) | 2025-10-16 | — | — | US | disclosed |
| US-12428406-B2 | Methods and compounds for restoring mutant p53 function | PMV PHARMACEUTICALS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12421213-B2 | Benzamides of pyrazolylamino- pyrimidinyl derivatives, and compositions and methods thereof | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2025-09-23 | — | — | US | disclosed |
| US-12358887-B2 | IKAROS Zinc Finger Family degraders and uses thereof | GILEAD SCIENCES, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| WO-1998045268-A1 | NICOTINAMIDE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 1998-10-15 | — | — | WO | disclosed |
| US-4783280-A | Liquid crystal mixture | HOFFMANN-LA ROCHE INC. (US) | 1988-11-08 | — | — | US | disclosed |
| US-4708441-A | LIQUID CRYSTALS | HOFFMAN-LA ROCHE INC. (US) | 1987-11-24 | — | — | US | disclosed |
| US-4550981-A | Liquid crystalline esters and mixtures | HOFFMANN-LA ROCHE INC. (US) | 1985-11-05 | — | — | US | disclosed |
| EP-0056113-B1 | CYCLOHEXYLCARBONITRILE DERIVATIVES, DIELECTRICS AND ELECTRO-OPTIC DISPLAY DEVICE CONTAINING THEM | MERCK PATENT GmbH (DE) | 1985-05-29 | — | — | EP | disclosed |
| US-4460770-A | Liquid crystal mixture | HOFFMANN-LA ROCHE INC. (US) | 1984-07-17 | — | — | US | disclosed |
| US-4419263-A | Liquid crystalline cyclohexylcarbonitrile derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-12-06 | — | — | US | disclosed |
| EP-0056113-A1 | Cyclohexylcarbonitrile derivatives, dielectrics and electro-optic display device containing them | MERCK PATENT GmbH (DE) | 1982-07-21 | — | — | EP | disclosed |
| EP-0034415-A1 | 1-(Cyclohexyl or cyclohexenyl)-4-aryl-4-piperidinecarboxylic acid derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1981-08-26 | — | — | EP | disclosed |